Article
Identification of EMT-related gene signatures in glioblastoma to aid immunotherapy and prognosis
2023-06-09
Abstract excerpt
<h4>Objective: </h4> Glioblastoma (GBM) is the most aggressive malignancy of the central nervous system, with the lowest survival rate of malignant brain tumors at approximately 6%. Epithelial mesenchymal transition (EMT) is closely associated with tumor metastasis and drug resistance. Therefore, it is necessary to construct models consisting of EMT-related genes (ERGs) to forecast prognosis and benefit from immun...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9bd3b4ff-fd6d-5f3c-9568-8c935026c0db
- DOI
- 10.21203/rs.3.rs-2981469/v1
